Ask Us Anything: Human Factors for In Vitro Diagnostics (IVDs)

In vitro diagnostics carry distinct human factors challenges, from CLIA waiver requirements to OTC transitions and the growing shift toward home-use environments. This Q&A session with ClariMed's IVD human factors experts addresses real questions on navigating regulatory expectations and implementing human factors engineering throughout the diagnostic device development lifecycle.

Key Topics Covered:

• CLIA waiver requirements and human factors evidence needed for at-home diagnostic devices

• FDA's URRA guidance implementation and critical task analysis for IVDs

• Best practices for validation testing across diverse user populations and use environments

• OTC transition strategies and regulatory considerations when moving diagnostics direct-to-consumer

• Strategies for integrating human factors engineering throughout the diagnostic device development lifecycle

• Home-use versus professional-use design considerations and their regulatory implications